Comprehensive Insights into the Development of Antitoxoplasmosis Drugs: Current Advances, Obstacles, and Future Perspectives
Journal of Medicinal Chemistry · 12.12.2024 · 67 (23) · 20740-20764
DOI: 10.1021/acs.jmedchem.4c01733 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 26.11.2024. Verfasst von Siyang Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Health Science Center, Ningbo University, No. 818 Fenghua Road, Jiangbei District, Ningbo 513211, China. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Toxoplasma, Toxoplasmosis. Die Arbeit wurde bisher 14-mal zitiert (Crossref) und nennt 180 Literaturangaben. Gefördert von: National Youth Science Foundation, Ningbo University, Natural Science Foundation of Zhejiang Province.
Abstract (Originalsprache)
Current therapies for toxoplasmosis rely on a few drugs, most of which have severe side effects, and seeking ideal therapies for different types of toxoplasmosis is a long-term and challenging mission. Research and development (R&D) of novel drugs against Toxoplasma gondii (T. gondii) has focused on two main directions, the structural modification of lead compounds and natural products. Here we summarize the recent advances in the development of anti-T. gondii drugs from these two perspectives and provide comprehensive insights, reflecting on the advantages and selected molecules in each field. This review also focuses on the current obstacles to the development of novel anti-T. gondii agents, proposes comprehensive solutions, and facilitates future development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Health Science Center, Ningbo University, No. 818 Fenghua Road, Jiangbei District, Ningbo 513211, China.
ORCID-Profile: Jili Zhang
Förderung
- National Youth Science Foundation
- Ningbo University
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Liu, S., Cai, M., Liu, Z., Gao, W., Li, J., Li, Y., Abudouxukuer, X., & Zhang, J. (2024). Comprehensive Insights into the Development of Antitoxoplasmosis Drugs: Current Advances, Obstacles, and Future Perspectives. Journal of Medicinal Chemistry, 67(23), 20740-20764. https://doi.org/10.1021/acs.jmedchem.4c01733
Vancouver
Liu S, Cai M, Liu Z, Gao W, Li J, Li Y, et al. Comprehensive Insights into the Development of Antitoxoplasmosis Drugs: Current Advances, Obstacles, and Future Perspectives. Journal of Medicinal Chemistry. 2024;67(23):20740-20764. doi:10.1021/acs.jmedchem.4c01733
BibTeX
@article{Liu2024,
author = {Liu, Siyang and Cai, Minghao and Liu, Zhendi and Gao, Weixin and Li, Junjie and Li, Yuxueqing and Abudouxukuer, Xiayire and Zhang, Jili},
title = {Comprehensive Insights into the Development of Antitoxoplasmosis Drugs: Current Advances, Obstacles, and Future Perspectives},
journal = {Journal of Medicinal Chemistry},
year = {2024},
volume = {67},
number = {23},
pages = {20740--20764},
doi = {10.1021/acs.jmedchem.4c01733}
}
EUVIMED